Loading news...
Stock News EV makers endure a volatile 2025: Tesla (TSLA), Rivian (RIVN) and Lucid (LCID) navigated slumping sales, model resets and shifting policies, while le
DEERFIELD, Ill.--(BUSINESS WIRE)--The holidays just got brighter- and more affordable - at Walgreens. From Black Friday through Christmas Day, shoppers can unlock the retailer's most exciting savings of the year, featuring its lowest prices of the season on must-have gifts and holiday essentials. From trending toys and family-favorite games to beauty, home necessities, and sweet treats, Walgreens is making it easier than ever to celebrate without breaking the budget. Here's what's coming up: Bl.
Insights from Jeremy Grantham (Trades, Portfolio)'s Third Quarter 2025 13F Filing Jeremy Grantham (Trades, Portfolio) recently submitted the 13F filing for the
Insights into Mario Gabelli (Trades, Portfolio)'s Third Quarter 2025 Investment Moves Mario Gabelli (Trades, Portfolio) recently submitted the 13F filing for t
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens announced today it is launching the Walgreens Pharmacy Patient Advisory Board to ensure patient voices continue to shape how it delivers pharmacy services, especially for those managing chronic and/or complex conditions. The Walgreens Pharmacy Patient Advisory Board is chaired by Rina Shah, senior vice president of enterprise specialty pharmacy at Walgreens. In addition to the patient members, the Board will also include Bob Stephen, vice president of.
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens has launched the 2025-2026 Respiratory Index, an interactive online tool that tracks flu and COVID-19 activity nationwide using prescription, testing and over the counter (OTC) product purchase data from Walgreens locations nationwide. This unique tool builds on more than a decade of insights from the Walgreens Flu Index to now offer a more comprehensive view of respiratory illness trends across the U.S., helping the public, healthcare providers, and.
Sycamore Partners said Thursday (Aug. 28) that it completed its acquisition of Walgreens Boots Alliance and that the businesses that made up WBA are now operating as standalone companies under private ownership. Those companies include Walgreens, The Boots Group, Shields Health Solutions, CareCentrix and VillageMD, Sycamore said in a Thursday press release.
Walgreens on Thursday named retail veteran Mike Motz as chief executive after the U.S. pharmacy chain was taken private by Sycamore Partners, marking a fresh chapter for the company that has been struggling to keep pace with rivals.
NEW YORK--(BUSINESS WIRE)--Sycamore Partners (“Sycamore”) announced today that it has completed its acquisition of Walgreens Boots Alliance, Inc. (the “Company” or “WBA”). Sycamore is acquiring the business in partnership with Stefano Pessina and his family, who have reinvested 100% of their interests in WBA, demonstrating their ongoing support and confidence in the Company's future. Stefan Kaluzny, Managing Director of Sycamore, said, “Walgreens Boots Alliance, Inc., its companies and its dedi.
The brokerage service is replacing Walgreens Boots Alliance, which is being taken private in a deal with Sycamore Partners that is expected to close soon. Interactive Brokers shares jumped nearly 5% in after-hours trading on the news.
NEW YORK , Aug. 25, 2025 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600: S&P MidCap 400 constituent Interactive Brokers Group Inc. (NASD: IBKR) will replace Walgreens Boots Alliance Inc. (NASD: WBA) in the S&P 500, and Talen Energy Corp. (NASD: TLN) will replace Interactive Brokers Group in the S&P MidCap 400 effective prior to the opening of trading on Thursday, August 28. Sycamore Partners is acquiring Walgreens Boots Alliance in a deal expected to be completed soon, pending final closing conditions.
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens Specialty Pharmacy has expanded its limited distribution drug (LDD) network to now include 265 products, placing it among the leading networks in specialty pharmacies. LDDs are specialty medications that are available through select specialty pharmacies chosen by the drug manufacturer and are often medications with complex regimens, high costs and/or require special handling. As the largest independent specialty pharmacy not directly affiliated with a.
Walgreens Boots Alliance (WBA 0.34%) has been a difficult stock to love for a few years, thanks to multiple corporate missteps. It got so bad that the board decided the best course of action was to effect a turnaround under private hands.
Market volatility from tariffs presents a buying opportunity for quality stocks, especially for long-term investors seeking value in the current dip. Otis Worldwide offers resilience and upside potential, with cost-saving initiatives and a strong dividend, despite near-term headwinds in China and tariffs. U.S. Bancorp remains fundamentally strong, with solid earnings, dividend growth, and upside potential if economic conditions stabilize and rates decline.
DEERFIELD, Ill.--(BUSINESS WIRE)--Walgreens is now offering flu shots for anyone three years and older at stores nationwide. Individuals and families can walk into their nearest Walgreens pharmacy or schedule an appointment by visiting Walgreens.com/ScheduleVaccine, through the Walgreens app or by calling 1-800-WALGREENS. Starting August 1, myWalgreens members will receive 20% off their next eligible purchase with any vaccine received—making it even more rewarding to stay healthy.* Community ph.
Shares of Realty Income (NYSE:O) gained 0.86% over the past month, bringing its year-to-date gain to 9.45%. In addition to outperforming the S&P 500’s gain of 8.61% in 2025, O has provided shareholders with a dividend currently yielding 5.60%. Realty Income remains a staple in dividend investors’ portfolios. The commercial REIT dividend — which pays out monthly and has for 659 consecutive months — is a large reason investors are confident in the stock moving forward. Another reason: its expanding footprint in the European market that has seen commercial properties with long-term net lease agreements added to its +13,000-property portfolio in the U.K., Spain and other countries. Billing itself “The Monthly Dividend Company,” the real estate investment trust (REIT) blazed a new path in the field that numerous other REITs now follow. The track record of payments for O is remarkable, and since being listed on the NYSE in 1994, the REIT has increased its dividend every quarter. Having raised the payout for 30 consecutive years, Realty Income is now a Dividend Aristocrat, or a stock that is part of the S&P 500 and has increased its dividend for 25 consecutive years or more. Since its IPO in 1994, Realty Income has provided investors with a 589.46% return, not including reinvested dividends. The question is, where does Realty Income stock go from here. 24/7 Wall St. offers readers insights into our assumptions about the stock’s prospects, what sort of growth we see in O stock for the next several years, and our best estimates for Reality Income stock price each year through 2030. Realty Income (O) Recent Stock Performance Here’s a table summarizing the performance in share price, revenues, and adjusted funds from operations (AFFO) of O stock from 2019 to 2024: Year Stock Price Revenue* Adjusted Funds From Operations (AFFO)* 2019 $71.30 $1.488 $1.050 2020 $60.20 $1.647 $1.172 2021 $71.59 $2.080 $1.488 2022 $63.43 $3.343 $2.401 2023 $57.42 $4.078 $2.774 2024 $52.60 $5.271 $3.621 *Revenue and AFFO $billions. The REIT ended 2019 on a high note, closing out the year with a 21% total return, but like the rest of the market, the next year would be turned upside down due to the pandemic. O stock ended 2020 with a greater than 11% loss. While Realty Income would bounce back sharply in 2022 with a 24% gain, it was a rally that could not be sustained due to rapidly rising inflation and a Federal Reserve determined to tame it. The central bank’s unprecedented 11 consecutive hikes in the federal funds rate would send the REIT market into a tailspin. That’s because REITs borrow money to invest in new real estate and the dramatically higher rates they pay hit their bottom line hard. Realty Income tried to mitigate that by hitting the equity markets. From 2013 to 2020, O’s shares outstanding rose at a fairly consistent 8.8% annually. The onset of inflation and spiraling interest rates saw the REITs stock issuance surge to a 26% compound annual growth rate from 2020 to 2023. The Fed started to lower rates this year, but as inflation flared anew, the rate-easing policy seems to be on hold. Through it all, however, Realty Income was able to continue increasing revenue and AFFO, which has surged 244.85% since 2019. The REIT has used those funds to continue rewarding shareholders with dividend hikes. Key Drivers of Realty Income’s Stock performance 1. Global & Industrial Expansion: The REIT’s commercial portfolio, which now includes more than 13,000 properties, is expanding its presence in Europe. Last year, it grew significantly in the U.K. and Spain, having signed a €527 million deal with Decathlon, one of the world’s leading sports brands. Additionally, it is working to expand its global industrial footprint, which accounted for just 15% of the REIT’s portfolio in 2024. 2. Quality Tenants: Although the shock to the system was significant, Realty Income was able to withstand the stress test due to the quality of its tenant base. It counts dozens of top-shelf retail outlets amongst its tenants, including Amazon (NASDAQ:AMZN), Starbucks (NASDAQ:SBUX) and Chipotle Mexican Grill (NYSE:CMG). 3. Diversification: Its three largest tenants by space leased are Dollar General (NYSE:DG), Walgreens Boots Alliance (NASDAQ:WBA) and Dollar Tree (NASDAQ:DLTR). Although the dollar stores and pharmacy chain are encountering headwinds of their own, none represents more than 3% of the total portfolio, meaning its broad diversification reduces the impact any one tenant will have. It has also expanded into industrial markets, gaming, and data centers, as well as having a growing geographical footprint. Realty Income (O) Stock Price Forecast for 2025 The current Wall Street median, one-year price target for Realty Income is $61.00, good for potential upside of 5.95% based on today’s share price. Of the 12 analysts covering Realty Income, the REIT receives a consensus “Hold” rating, with three analysts assigning it a “Buy” rating, nine assigning it a “Hold” rating and zero assigning it a “Sell” rating. Their one-year price targets range from $68.00 per share to $58.00 per share. However, 24/7 Wall St. sets its one-year price target for Realty Income at $61.70 per share, good for potential upside of 7.17% based on today’s share price. If we compare O’s price-to-AFFO versus its peers — such as Agree Realty (NYSE:ADC) or Simon Property Group (NYSE:SPG) — we see they trade at an average P/AFFO of 12.31, while O goes for 10.52. Realty Income’s Estimates 2026–2030 Valuing Realty Income’s stock price for the coming years, we will take a look at expected revenue and AFFO and give our best estimate of the market value of the company by assigning a price-to-AFFO multiple. Year Revenue* AFFO* 2026 $3.87 $3.263 2027 $4.652 $3.837 2028 $5.582 $4.512 2029 $6.699 $5.307 2030 $8.039 $6.241 *Revenue and AFFO in thousands. Realty Income (O) Stock Price Forecast for 2025–2030 Although Realty Income’s stock has steadily risen as the interest rate environment improved and because it no longer needs to to issue significant amounts of stock to offset borrowing costs, the REIT has continued to increase its dividend every quarter for the past six years. Its total return handily surpasses that of the S&P 500. For 2030, we estimate AFFO reaches $6.2 billion with a P/AFFO of around 16, still well below its 10-year average, but more in line with many of its peers. That gives us a price target of $86.43 per share, or 50.13% potential upside from today’s share price. Year Price Target %Change From Current Price 2025 $61.70 7.17% 2026 $69.15 20.11% 2027 $70.84 23.05% 2028 $80.10 39.13% 2029 $82.13 42.66% 2030 $86.43 50.13% The post Realty Income (NYSE: O) Stock Price Prediction and Forecast 2025-2030 (July 2025) appeared first on 24/7 Wall St..
Walgreens Boots Alliance's (WBA 0.17%) stores dot the U.S. landscape, given that it is one of the largest pharmacy retailers in the country. But as an investment, well, it hasn't performed very well for a little while.
CLINTON, CT — An ALDI grocery store is planned for a site in Clinton. The store is being advertised in a real estate flyer for a site at 224 to 230 E. Main St. Tyler Lyman, of True Commercial Real Estate, LLC, said that there is no opening date yet for the store. The store is expected to be 20,664 square ft. Parking at the site will be between 105 and 110 spaces. No plans have been filed with the town. Plans are still subject to local approvals, according to The Connecticut Scoop. The real estate flyer notes that the center is "in the heart of Clinton's 'daily needs' retail district and conveniently located on Route 1 and only minutes from I-95." There are available spaces at the site for lease that are 2,500 square feet and 7,150 square feet, respectively. Other area retailers include Stop & Shop, Auto Zone, Walgreens, Dunkin', Shop Rite, and Advance Auto Parts. ALDI did not respond to a request for comment. The popular discount grocer currently has over 30 locations across the state. The company has set its eyes on a few possible locations for future stores in Connecticut. In Stratford, reports indicate a new ALDI grocery store is being proposed to be built at the Stratford Square shopping plaza on Barnum Avenue. A public hearing regarding the possible addition of an ALDI discount grocery store on Route 5 in East Windsor was held in April. A new mixed-use plaza with an ALDI and a Starbucks was also proposed in Stonington. Related: Beloved Grocery Store With Over 30 CT Stores Drops Prices On Hundreds Of Items New Aldi Store Proposed In Stratford: Report Grocery Store, Coffee Shop, Massive Residential Development Pitched For Stonington